Back to Media Center Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes Joint Steering Committee between Launch Therapeutics and Gilead Sciences Abingworth Announces a Strategic Development Financing Agreement with...
Back to Media Center Pathalys Pharma and Launch Therapeutics Announce First Patient Enrolled Ahead of Schedule in Pivotal Phase 3 Program for Upacicalcet in Patients Receiving Hemodialysis Pathalys and LaunchTx leverage recently announced collaboration to accelerate...
